Wave Life Sciences Ltd. (WVE)
Develops RNA medicines to treat genetic diseases like muscular dystrophy and Huntington's disease.
$5.89-0.01%Healthcare
StockGlow Score
Leaning Bearish
BearishBullish
1 year ago-31.7%
The outlook
Wave Life Sciences is trading near its 52-week low, well below both its 50- and 200-day moving averages. Analyst sentiment leans bearish overall, though the average price target sits roughly 272% above the current price, reflecting a wide gap between current market pricing and longer-term analyst expectations. The stock's position near multi-month lows suggests recent downward pressure.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range5% of the way from its 52-week low to high
Price targetAvg target +272% vs current price
Analyst price target
~12-month · 16 analysts$21.94average target+272.5% vs now
Now $5.89
Low $12.00High $43.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$1.13B
52-wk high
$21.73
52-wk low
$5.02
50-day avg
$6.05
200-day avg
$9.64
Trailing P/E
—